The American Heart Assn. calls them "game changers." Oprah Winfrey says they're "a gift." Science magazine anointed them the "2023 Breakthrough of the Year." Americans are most familiar with their brand names: Ozempic, Wegovy, Mounjaro, Zepbound. They are the medications that have revolutionized weight loss and raised the possibility of reversing the country's obesity crisis. Obesity — like so many diseases — disproportionately affects people in racial and ethnic groups that have been... Read this story
